Localization and potential role of prostate microbiota.

beneign prostate hyperplasia benign prostate enlargement in situ hybridization microbiome microbiota prostate

Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 19 09 2022
accepted: 09 11 2022
entrez: 26 12 2022
pubmed: 27 12 2022
medline: 28 12 2022
Statut: epublish

Résumé

We aimed to clarify the presence and localization of the prostate microbiota and examine its association with benign prostate enlargement (BPE). The microbiota of prostate tissues and catheterized urine from 15 patients were analyzed by 16S metagenomic analysis and compared to show that the prostate microbiota was not a contaminant of the urinary microbiota. Fluorescence in situ hybridization (FISH) and in situ hybridization (ISH) using the specific probe for eubacteria was performed on prostate tissue to show the localization of bacteria in the prostate. The BPE group was defined as prostate volume ≥30 mL, and the non-BPE group as prostate volume <30 mL. The microbiota of the two groups were compared to clarify the association between prostate microbiota and BPE. Faith's phylogenetic diversity index of prostate tissue was significantly higher than that of urine (42.3±3.8 vs 25.5±5.6, P=0.01). Principal coordinate analysis showed a significant difference between the microbiota of prostate tissue and catheterized urine (P<0.01). FISH and ISH showed the presence of bacteria in the prostatic duct. Comparison of prostate microbiota between the BPE and non-BPE groups showed that the Chao1 index of the BPE group was significantly lower than that of the latter [142 (50-316) vs 169 (97-665), P=0.047] and the abundance of Burkholderia was significantly higher in the BPE group than in the latter. We demonstrated that the prostate microbiota was located in the prostatic duct and reduced diversity of prostate microbiota was associated with BPE, suggesting that prostate microbiota plays a role in BPE.

Identifiants

pubmed: 36569206
doi: 10.3389/fcimb.2022.1048319
pmc: PMC9768196
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1048319

Informations de copyright

Copyright © 2022 Okada, Takezawa, Tsujimura, Imanaka, Kuribayashi, Ueda, Hatano, Fukuhara, Kiuchi, Fujita, Motooka, Nakamura, Koyama, Shimada and Nonomura.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Exp Dermatol. 2016 Jan;25(1):3-9
pubmed: 26269388
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Cell Host Microbe. 2020 Aug 12;28(2):298-305.e3
pubmed: 32697939
BJU Int. 2021 Apr;127(4):389-399
pubmed: 32893964
Eur Urol. 2017 Oct;72(4):625-631
pubmed: 28434677
Can J Urol. 2015 Oct;22 Suppl 1:1-6
pubmed: 26497338
Int Immunol. 2021 Jun 18;33(7):359-372
pubmed: 33822948
Prostate. 2020 Nov;80(15):1341-1352
pubmed: 32835423
Eur Urol. 2010 Jan;57(1):123-31
pubmed: 19825505
Int J Mol Sci. 2022 Mar 23;23(7):
pubmed: 35408838
Int J Mol Sci. 2021 May 31;22(11):
pubmed: 34073143
BJU Int. 2008 Sep;102(8):981-6
pubmed: 18549433
Prostate. 2021 Dec;81(16):1287-1293
pubmed: 34516694
Annu Rev Physiol. 2016;78:481-504
pubmed: 26527186
J Clin Microbiol. 2012 Apr;50(4):1376-83
pubmed: 22278835
Appl Environ Microbiol. 1990 Jun;56(6):1919-25
pubmed: 2200342
J Urol. 2021 Oct;206(4):806-817
pubmed: 34384237
BMC Genomics. 2021 Jul 10;22(1):527
pubmed: 34246242
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
Cytometry. 1993;14(2):136-43
pubmed: 7679962
Eur Urol Focus. 2020 Mar 15;6(2):361-369
pubmed: 30270128
Sci Rep. 2021 Dec 9;11(1):23758
pubmed: 34887510
Eur Urol. 2008 Dec;54(6):1379-84
pubmed: 18036719
Curr Urol Rep. 2008 Jul;9(4):272-8
pubmed: 18765125
Microbiology (Reading). 2009 Sep;155(Pt 9):2809-2817
pubmed: 19542002
Sci Transl Med. 2014 Jan 22;6(220):220ra11
pubmed: 24452263
J Urol. 2020 Jan;203(1):171-178
pubmed: 31430232
Cell Microbiol. 2014 Jul;16(7):1024-33
pubmed: 24798552
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Urol Clin North Am. 2016 Aug;43(3):289-97
pubmed: 27476122

Auteurs

Koichi Okada (K)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Kentaro Takezawa (K)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Go Tsujimura (G)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Takahiro Imanaka (T)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Sohei Kuribayashi (S)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Norichika Ueda (N)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Koji Hatano (K)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Shinichiro Fukuhara (S)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Hiroshi Kiuchi (H)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Kazutoshi Fujita (K)

Department of Urology, Faculty of Medicine, Kindai University Hospital, Osakasayama, Japan.

Daisuke Motooka (D)

Department of Infection Metagenomics, Genome Information Research Center, Osaka University Research Institute for Microbial Diseases, Suita, Japan.

Shota Nakamura (S)

Department of Infection Metagenomics, Genome Information Research Center, Osaka University Research Institute for Microbial Diseases, Suita, Japan.

Yoshihisa Koyama (Y)

Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.

Shoichi Shimada (S)

Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, Suita, Japan.

Norio Nonomura (N)

Department of Urology, Osaka University of Graduate School of Medicine, Suita, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH